Methanandamide
Chemical compound
From Wikipedia, the free encyclopedia
Methanandamide (AM-356) is a synthetically created stable chiral analog of anandamide with improved metabolic stability.[1] Its effects have been observed to act on the cannabinoid receptors (specifically on CB1 receptors,[2] which are part of the central nervous system) found in different organisms such as mammals, fish, and certain invertebrates (e.g. Hydra).[3][4][5]
| Names | |
|---|---|
| Preferred IUPAC name
(5Z,8Z,11Z,14Z)-N-[(2R)-1-Hydroxypropan-2-yl]icosa-5,8,11,14-tetraenamide | |
| Other names
AM-356; Arachidonyl-1'-hydroxy-2'-propylamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C23H39NO2 | |
| Molar mass | 361.570 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
